Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BHMT | Q93088 | 7/20 | 0.59 |
| ▸ | GSR | P00390 | 1/20 | 0.52 |
| ▸ | BHMT2 | Q9H2M3 | 1/20 | 0.51 |
| ▸ | NOS2 | P35228 | 4/20 | 0.47 |
| ▸ | NOS1 | P29475 | 4/20 | 0.47 |
| ▸ | NOS3 | P29474 | 3/20 | 0.47 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.47 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.47 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.47 |
| ▸ | ARG2 | P78540 | 4/20 | 0.47 |
| ▸ | ARG1 | P05089 | 3/20 | 0.47 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28251214 | 0.98 | BHMT (0.60) | BHMTGSRBHMT2NOS2NOS1 | |
| SCHEMBL1158177 | 0.94 | BHMT (0.56) | BHMTGSRBHMT2NOS2NOS1 | |
| SCHEMBL28251120 | 0.93 | BHMT (0.59) | BHMTGSRBHMT2NOS2NOS1 | |
| SCHEMBL28042282 | 0.91 | BHMT (0.60) | BHMTGSRBHMT2NOS2NOS1 | |
| SCHEMBL31710807 | 0.87 | BHMT (0.56) | BHMTGSRBHMT2NOS2NOS1 | |
| SCHEMBL2455928 | 0.87 | BHMT (0.56) | BHMTGSRBHMT2NOS2NOS1 | |
| SCHEMBL5285668 | 0.87 | BHMT (0.56) | BHMTGSRBHMT2NOS2NOS1 | |
| SCHEMBL474910 | 0.86 | BHMT (0.67) | BHMTBHMT2NOS2NOS1NOS3 | |
| SCHEMBL2119412 | 0.86 | BHMT (0.67) | BHMTBHMT2NOS2NOS1NOS3 | |
| SCHEMBL474911 | 0.86 | BHMT (0.67) | BHMTBHMT2NOS2NOS1NOS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105130871-B | A kind of sulfur derivatives and its preparation method and application of pyrrolin ketone | 南京农业大学 | 2018-11-09 | — | — | CN | disclosed |
| EP-2550251-B1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACID OR SALT THEREOF | SUMITOMO CHEMICAL CO (JP) | 2015-04-29 | — | — | EP | disclosed |
| US-8779190-B2 | Process for producing sulfur-containing amino acid or salt thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-07-15 | — | — | US | disclosed |
| EP-2550251-A1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACID OR SALT THEREOF | Sumitomo Chemical Company, Limited (JP) | 2013-01-30 | — | — | EP | disclosed |
| US-20130012737-A1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACID OR SALT THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-01-10 | — | — | US | disclosed |
| WO-2011118849-A1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACID OR SALT THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-09-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130012737-A1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACID OR SALT THEREOF | CBS, ASS1, TST | BHMT 1148/4885GSR 2492/4885BHMT2 190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.